DrugDashboards

Moxifloxacin Ophthalmic Solution

Moxifloxacin Ophthalmic · MOXIFLOXACIN HYDROCHLORIDE 5 mg/mL · Solution/ Drops · Ophthalmic · Fosun Pharma USA Inc.

NDC 72266-0158-01 · 1 BOTTLE in 1 CARTON / 3 mL in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 19% over the past year, to $1.54 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.00$4.00$6.00Mar 2021Sep 2026$1.54
67 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$11.60
Reported to Texas DSHS · 2026 annual filing · Fosun Pharma

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$104,244
7,678 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 3 active manufacturers+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for moxifloxacin (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA208778
TE code
AT1
Approval date
Mar 30, 2020
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Moxifloxacin Ophthalmic (Solution/ Drops)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsMOXIFLOXACIN HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Fosun Pharma USA Inc.MOXIFLOXACIN HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedMOXIFLOXACIN HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Moxifloxacin Ophthalmic Solution — NDC 72266-0158-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72266015801.

Free to cite with attribution — see how the data is put together.